21-42385484-C-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001256317.3(TMPRSS3):c.497G>T(p.Arg166Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000443 in 1,614,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001256317.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMPRSS3 | NM_001256317.3 | c.497G>T | p.Arg166Leu | missense_variant | 6/13 | ENST00000644384.2 | NP_001243246.1 | |
TMPRSS3 | NM_024022.4 | c.497G>T | p.Arg166Leu | missense_variant | 6/13 | NP_076927.1 | ||
TMPRSS3 | NM_032405.2 | c.497G>T | p.Arg166Leu | missense_variant | 6/9 | NP_115781.1 | ||
TMPRSS3 | NM_032404.3 | c.116G>T | p.Arg39Leu | missense_variant | 3/10 | NP_115780.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMPRSS3 | ENST00000644384.2 | c.497G>T | p.Arg166Leu | missense_variant | 6/13 | NM_001256317.3 | ENSP00000494414 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152174Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000644 AC: 162AN: 251488Hom.: 0 AF XY: 0.000603 AC XY: 82AN XY: 135922
GnomAD4 exome AF: 0.000439 AC: 642AN: 1461876Hom.: 1 Cov.: 31 AF XY: 0.000406 AC XY: 295AN XY: 727244
GnomAD4 genome AF: 0.000479 AC: 73AN: 152292Hom.: 0 Cov.: 30 AF XY: 0.000658 AC XY: 49AN XY: 74462
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 8 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 18, 2020 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 30, 2017 | The R166L variant in the TMPRSS3 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R166L variant is observed in 19/6614 (0.3%) alleles from individuals of European background, in the ExAC dataset (Lek et al., 2016). The R166L variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret R166L as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 02, 2016 | p.Arg166Leu in Exon 6 of TMPRSS3: This variant is not expected to have clinical significance because it has been identified in 0.3% (19/6614) of Finnish chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs150397427). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at